• Folliculogenesis, ovarian biology and oocyte quality
• Poor ovarian response, stimulation failure, POF/POI
• Endocrine disorders (PCOS, thyroid dysfunction, diabetes)
• Vaginal and uterine microbiome in female fertility
• Biomarkers and novel therapeutic strategies

• Advances in IVF, ICSI, IVM and embryo culture
• Non-invasive embryo assessment and morphokinetics
• Fertility preservation and oncofertility
• Tissue engineering, ovarian and endometrial organoids, stem cells
• Bioengineering, microfluidics, bioprinting and IVF lab automation
• ART in veterinary species and animal biotechnology

• Molecular genetics of infertility
• Genome editing and future applications
• Epigenetics in gametes, embryo development and offspring health
• Aneuploidy, PGT and embryo assessment
• Long-term health of ART-conceived children

• Implantation immunology and embryo–endometrium interaction
• Immunotherapies for RIF and immune-related infertility
• Endometriosis, adenomyosis and chronic pelvic inflammation
• Novel anti-inflammatory and immunomodulatory treatments

• Müllerian anomalies, fibroids, adenomyosis, isthmocele
• Advanced imaging
• Diagnostic and operative hysteroscopy
• High-risk pregnancies: ectopic, molar, multiple, IUGR

• Uterine and vaginal microbiome and its impact on ART outcomes
• Reproductive infections and infertility
• Obesity, insulin resistance and metabolic dysfunction
• ART management in diabetes, thyroid disorders and autoimmune diseases

• Environmental pollutants, toxins and occupational exposures
• Reproductive aging and anti-aging strategies
• Lifestyle, sleep, physical activity and nutrition
• Integrative and complementary medicine in infertility
• Preventive reproductive health

• AI for embryo selection and IVF outcome prediction
• Multi-omics data integration and ARTx modeling
• Digital health, telemedicine and smart fertility clinics
• Robotics and automation in IVF laboratories

• Gamete and embryo donation, surrogacy
• Ethics of genome editing and sex selection
• Reproductive justice and equitable access to ART
• Cross-border reproductive care and regulatory standards

• Emerging treatments in male and female infertility
• Management of RIF, RPL and unexplained infertility
• Personalized ART strategies
• Future technologies and next-generation reproductive medicine